I know we use Twitter as our muse for a lot of our episodes, but this week, we glean some inspiration from the bright sunshine of the real, non-Internet world. Yes, we get to see the light of day sometimes. Recently, I was refilling a prescription at my drugstore and was informed that the 20-day supply of pills (nine pills) that I was given the last time I filled my prescription was not up yet. This meant that my insurance would not cover the prescription until a few days later.
Given that the prescription is for migraines, my pharmacist offered to sell two pills directly to me. This meant that I would have to pay full price—two pills for about $41. I thought about it for a moment and decided to make the purchase.
I was thankful that my pharmacy offered me that option and it got me thinking about a few different things. First, there was the basic economic problem that I was confronted with: what’s more valuable to me, the two pills or the $41? What complicated the matter a little bit was that I not only had to think about what my current preferences were but also what my future preferences would likely be (if I had a migraine coming on).
But there was a bigger and more important thought that popped into my head: why is medication like this something that my insurance would cover? And coupled to this idea, why does a small, mass produced pill cost more than $20? Slappy and I seek answers in this week’s episode.
Mance Rayder, the host of the Free Man Beyond the Wall podcast, invited me onto his show yesterday to talk about how insurance and free market regulation could help privatize a world whose markets are so corrupted and fettered by the state. Check out and subscribe to his podcast and give my appearance a listen: Episode 72: Talking Privatization of All Things w/ Rollo McFloogle.
Keep in touch with us everywhere you are
Like us on Facebook
Follow us on Twitter: @RolloMcFloogle @Slappy_Jones_2
Follow us on Gab.ai
Follow us on our Steemit page
Check us out on Patreon
Check us out on Hatreon
Like what you’re reading? Let us keep in touch and subscribe to us!